Mechanistically, the interaction between CXCL12 and CXCR4 results in activation of many survival pathways including PI3K-AKT and mitogen-activated protein kinase (MAPK) signaling cascades in T-ALL cells [68] (Figure 2A). The gene discussed is CXCL12; the disease is acute lymphoblastic leukemia.